HEADER HYDROLASE/INHIBITOR 05-OCT-22 8EP6 TITLE CRYSTAL STRUCTURE OF THE BETA-LACTAMASE CLASS D FROM CHITINOPHAGA TITLE 2 PINENSIS IN COMPLEX WITH AVIBACTAM COMPND MOL_ID: 1; COMPND 2 MOLECULE: BETA-LACTAMASE CLASS D CPIN_0907; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CHITINOPHAGA PINENSIS DSM 2588; SOURCE 3 ORGANISM_TAXID: 485918; SOURCE 4 STRAIN: DSM 2588; SOURCE 5 GENE: BLAOXA, FEF09_01595; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_VARIANT: GOLD; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PMCSG53 KEYWDS BETA LACTAMASE CLASS D, AVIBACTAM, ANTIBIOTIC RESISTANCE, KEYWDS 2 TRANSPEPTIDASE, CENTER FOR STRUCTURAL BIOLOGY OF INFECTIOUS KEYWDS 3 DISEASES, CSBID, STRUCTURAL GENOMICS, CENTER FOR STRUCTURAL GENOMICS KEYWDS 4 OF INFECTIOUS DISEASES, CSGID, HYDROLASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR N.MALTSEVA,Y.KIM,M.ENDRES,A.JOACHIMIAK,CENTER FOR STRUCTURAL GENOMICS AUTHOR 2 OF INFECTIOUS DISEASES (CSGID),CENTER FOR STRUCTURAL BIOLOGY OF AUTHOR 3 INFECTIOUS DISEASES (CSBID) REVDAT 2 01-FEB-23 8EP6 1 AUTHOR REVDAT 1 19-OCT-22 8EP6 0 JRNL AUTH N.MALTSEVA,Y.KIM,M.ENDRES,A.JOACHIMIAK JRNL TITL CRYSTAL STRUCTURE OF THE BETA-LACTAMASE CLASS D FROM JRNL TITL 2 CHITINOPHAGA PINENSIS IN THE COMPLEX WITH AVIBACTAM. JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.20.1_4487 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 34.35 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.380 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 3 NUMBER OF REFLECTIONS : 36913 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.147 REMARK 3 R VALUE (WORKING SET) : 0.145 REMARK 3 FREE R VALUE : 0.187 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.050 REMARK 3 FREE R VALUE TEST SET COUNT : 1865 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 34.3500 - 3.5300 0.99 2868 162 0.1539 0.1753 REMARK 3 2 3.5300 - 2.8000 0.99 2753 138 0.1639 0.2008 REMARK 3 3 2.8000 - 2.4500 0.99 2693 167 0.1573 0.2028 REMARK 3 4 2.4500 - 2.2200 1.00 2723 137 0.1380 0.1748 REMARK 3 5 2.2200 - 2.0600 1.00 2712 156 0.1284 0.1711 REMARK 3 6 2.0600 - 1.9400 0.99 2701 118 0.1182 0.1511 REMARK 3 7 1.9400 - 1.8400 1.00 2717 129 0.1123 0.1819 REMARK 3 8 1.8400 - 1.7600 1.00 2688 140 0.1202 0.1783 REMARK 3 9 1.7600 - 1.7000 0.99 2653 143 0.1301 0.2029 REMARK 3 10 1.7000 - 1.6400 0.99 2678 121 0.1354 0.2097 REMARK 3 11 1.6400 - 1.5900 0.99 2670 150 0.1356 0.2159 REMARK 3 12 1.5900 - 1.5400 0.99 2648 159 0.1534 0.2228 REMARK 3 13 1.5400 - 1.5000 0.96 2544 145 0.1668 0.2428 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.141 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 16.999 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 16.55 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 22.61 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.013 2177 REMARK 3 ANGLE : 1.249 2947 REMARK 3 CHIRALITY : 0.074 305 REMARK 3 PLANARITY : 0.011 380 REMARK 3 DIHEDRAL : 13.361 823 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8EP6 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-OCT-22. REMARK 100 THE DEPOSITION ID IS D_1000268399. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-DEC-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 19-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97926 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 X 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-3000 REMARK 200 DATA SCALING SOFTWARE : HKL-3000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 37009 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.500 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 6.200 REMARK 200 R MERGE (I) : 0.13100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.53 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.1 REMARK 200 DATA REDUNDANCY IN SHELL : 5.80 REMARK 200 R MERGE FOR SHELL (I) : 0.84500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SAD REMARK 200 SOFTWARE USED: HKL-3000, MLPHARE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 37.21 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.96 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M IMIDAZOLE, PH 6.5, 0.2 M SODIUM REMARK 280 ACETATE, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 24.40800 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 34.34900 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 33.93200 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 34.34900 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 24.40800 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 33.93200 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10910 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASN A 21 REMARK 465 ASN A 22 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 56 69.70 72.55 REMARK 500 ALA A 67 -136.61 46.19 REMARK 500 ASN A 104 54.72 -90.70 REMARK 500 THR A 129 153.03 86.66 REMARK 500 SER A 148 -81.42 -85.32 REMARK 500 SER A 158 -76.72 -70.14 REMARK 500 PHE A 263 5.31 85.06 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 7K3M RELATED DB: PDB REMARK 900 THE SAME PROTEIN WITHOUT A LIGAND BOUND REMARK 900 RELATED ID: IDP97247 RELATED DB: TARGETTRACK DBREF 8EP6 A 21 267 PDB 8EP6 8EP6 21 267 SEQRES 1 A 247 ASN ASN VAL GLU ASN GLU LYS SER TRP GLU LYS TYR PHE SEQRES 2 A 247 ALA GLU TYR LYS VAL GLU GLY CYS PHE MSE LEU PHE ASN SEQRES 3 A 247 ASN SER GLN GLY THR PHE LYS VAL TYR ASN LEU GLU ARG SEQRES 4 A 247 SER GLN GLN ARG PHE LEU PRO ALA SER THR PHE KCX ILE SEQRES 5 A 247 PHE ASN SER LEU VAL GLY LEU GLU THR GLY VAL ILE LYS SEQRES 6 A 247 ASP THR SER PHE VAL ILE PRO TRP ASP GLY VAL THR ARG SEQRES 7 A 247 ASP MSE PRO GLU TRP ASN HIS ASP LEU SER MSE GLN GLN SEQRES 8 A 247 ALA PHE ARG VAL SER ALA VAL PRO TYR PHE GLN GLU VAL SEQRES 9 A 247 ALA ARG ARG ILE THR LYS PRO VAL MSE GLN HIS TRP LEU SEQRES 10 A 247 ASP THR VAL LYS PHE GLY ASN MSE LYS ILE SER LYS ILE SEQRES 11 A 247 ASP THR PHE TRP LEU ASP ASN SER LEU GLN ILE SER PRO SEQRES 12 A 247 ASP GLU GLU LEU GLY PHE VAL LYS LYS LEU TYR PHE ASP SEQRES 13 A 247 GLN LEU PRO PHE HIS LYS VAL THR MSE GLN ASN VAL ARG SEQRES 14 A 247 GLN VAL MSE LEU MSE GLU LYS LYS PRO GLU TYR GLU LEU SEQRES 15 A 247 SER TYR LYS THR GLY MSE GLY PHE SER GLY PRO LYS THR SEQRES 16 A 247 ILE GLY TRP ILE THR GLY TRP ILE GLU GLU ASN GLY HIS SEQRES 17 A 247 PRO SER PHE PHE VAL LEU ASN ILE GLU THR GLU ASN LYS SEQRES 18 A 247 SER LEU ASP MSE ARG THR VAL ARG MSE ASN ILE LEU ARG SEQRES 19 A 247 ASN LEU LEU THR ASP ALA GLY TYR PHE LYS GLY MSE LYS MODRES 8EP6 MSE A 43 MET MODIFIED RESIDUE MODRES 8EP6 KCX A 71 LYS MODIFIED RESIDUE MODRES 8EP6 MSE A 100 MET MODIFIED RESIDUE MODRES 8EP6 MSE A 109 MET MODIFIED RESIDUE MODRES 8EP6 MSE A 133 MET MODIFIED RESIDUE MODRES 8EP6 MSE A 145 MET MODIFIED RESIDUE MODRES 8EP6 MSE A 185 MET MODIFIED RESIDUE MODRES 8EP6 MSE A 192 MET MODIFIED RESIDUE MODRES 8EP6 MSE A 194 MET MODIFIED RESIDUE MODRES 8EP6 MSE A 208 MET MODIFIED RESIDUE MODRES 8EP6 MSE A 245 MET MODIFIED RESIDUE MODRES 8EP6 MSE A 250 MET MODIFIED RESIDUE MODRES 8EP6 MSE A 266 MET MODIFIED RESIDUE HET MSE A 43 8 HET KCX A 71 12 HET MSE A 100 8 HET MSE A 109 16 HET MSE A 133 8 HET MSE A 145 8 HET MSE A 185 8 HET MSE A 192 8 HET MSE A 194 8 HET MSE A 208 8 HET MSE A 245 8 HET MSE A 250 8 HET MSE A 266 8 HET NXL A 301 17 HET ACY A 302 4 HETNAM MSE SELENOMETHIONINE HETNAM KCX LYSINE NZ-CARBOXYLIC ACID HETNAM NXL (2S,5R)-1-FORMYL-5-[(SULFOOXY)AMINO]PIPERIDINE-2- HETNAM 2 NXL CARBOXAMIDE HETNAM ACY ACETIC ACID HETSYN NXL AVIBACTAM, BOUND FORM; NXL104, BOUND FORM FORMUL 1 MSE 12(C5 H11 N O2 SE) FORMUL 1 KCX C7 H14 N2 O4 FORMUL 2 NXL C7 H13 N3 O6 S FORMUL 3 ACY C2 H4 O2 FORMUL 4 HOH *95(H2 O) HELIX 1 AA1 TRP A 29 GLU A 35 1 7 HELIX 2 AA2 ASN A 56 GLN A 61 1 6 HELIX 3 AA3 PRO A 66 THR A 69 5 4 HELIX 4 AA4 PHE A 70 THR A 81 1 12 HELIX 5 AA5 MSE A 100 ASN A 104 5 5 HELIX 6 AA6 MSE A 109 SER A 116 1 8 HELIX 7 AA7 ALA A 117 THR A 129 1 13 HELIX 8 AA8 THR A 129 LYS A 141 1 13 HELIX 9 AA9 SER A 162 PHE A 175 1 14 HELIX 10 AB1 HIS A 181 MSE A 192 1 12 HELIX 11 AB2 ASP A 244 ALA A 260 1 17 SHEET 1 AA1 7 GLU A 24 ASN A 25 0 SHEET 2 AA1 7 THR A 51 TYR A 55 1 O PHE A 52 N GLU A 24 SHEET 3 AA1 7 GLU A 39 ASN A 46 -1 N ASN A 46 O THR A 51 SHEET 4 AA1 7 HIS A 228 THR A 238 -1 O PHE A 231 N PHE A 45 SHEET 5 AA1 7 LYS A 214 GLU A 225 -1 N GLY A 217 O ILE A 236 SHEET 6 AA1 7 TYR A 200 SER A 211 -1 N GLY A 209 O ILE A 216 SHEET 7 AA1 7 LEU A 193 LYS A 197 -1 N GLU A 195 O LEU A 202 SHEET 1 AA2 2 VAL A 90 ILE A 91 0 SHEET 2 AA2 2 LEU A 107 SER A 108 -1 O LEU A 107 N ILE A 91 LINK C PHE A 42 N MSE A 43 1555 1555 1.34 LINK C MSE A 43 N LEU A 44 1555 1555 1.33 LINK OG SER A 68 CAN NXL A 301 1555 1555 1.38 LINK C PHE A 70 N KCX A 71 1555 1555 1.35 LINK C KCX A 71 N ILE A 72 1555 1555 1.34 LINK C ASP A 99 N MSE A 100 1555 1555 1.33 LINK C MSE A 100 N PRO A 101 1555 1555 1.33 LINK C SER A 108 N AMSE A 109 1555 1555 1.33 LINK C SER A 108 N BMSE A 109 1555 1555 1.32 LINK C AMSE A 109 N GLN A 110 1555 1555 1.34 LINK C BMSE A 109 N GLN A 110 1555 1555 1.34 LINK C VAL A 132 N MSE A 133 1555 1555 1.33 LINK C MSE A 133 N GLN A 134 1555 1555 1.33 LINK C ASN A 144 N MSE A 145 1555 1555 1.34 LINK C MSE A 145 N ALYS A 146 1555 1555 1.34 LINK C MSE A 145 N BLYS A 146 1555 1555 1.33 LINK C THR A 184 N MSE A 185 1555 1555 1.32 LINK C MSE A 185 N GLN A 186 1555 1555 1.34 LINK C VAL A 191 N MSE A 192 1555 1555 1.33 LINK C MSE A 192 N LEU A 193 1555 1555 1.32 LINK C LEU A 193 N MSE A 194 1555 1555 1.33 LINK C MSE A 194 N GLU A 195 1555 1555 1.32 LINK C GLY A 207 N MSE A 208 1555 1555 1.33 LINK C MSE A 208 N GLY A 209 1555 1555 1.32 LINK C ASP A 244 N MSE A 245 1555 1555 1.33 LINK C MSE A 245 N ARG A 246 1555 1555 1.33 LINK C ARG A 249 N MSE A 250 1555 1555 1.32 LINK C MSE A 250 N ASN A 251 1555 1555 1.33 LINK C GLY A 265 N MSE A 266 1555 1555 1.32 LINK C MSE A 266 N LYS A 267 1555 1555 1.33 CRYST1 48.816 67.864 68.698 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020485 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014735 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014556 0.00000